Sagimet Biosciences Inc. (SGMT) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$45.65M | -7.6% |
| 2024 | -$42.44M | -78.6% |
| 2023 | -$23.77M | +3.0% |
| 2022 | -$24.49M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$45.65M | -7.6% |
| 2024 | -$42.44M | -78.6% |
| 2023 | -$23.77M | +3.0% |
| 2022 | -$24.49M | — |